NÁDORY JATER - úvodem

Vladislav Třeška

Onkologie. 2008:2(4):214  

DIAGNOSING LIVER CANCER

Tomáš Skalický, Vladislav Třeška, Jiří Ferda, Hynek Mírka

Onkologie. 2008:2(4):215-217  

Establishing a diagnosis of liver cancer is a rather complex interdisciplinary process, the aim of which is to determine the type, number, and size of liver tumours, and to assess their potential operability. Thus, the following must be involved in the diagnostic process: a radiologist, hepatologist, surgeon, and oncologist. Currently used imaging techniques primarily include ultrasound examination combined with CT scan, in certain cases supplemented with magnetic resonance imaging or PET/CT imaging. The reliability of imaging techniques is relatively good in tumour foci over 1 cm in diameter, however, it is greatly diminished in those smaller...

SURGICAL TREATMENT FOR LIVER CANCER

Vladislav Třeška

Onkologie. 2008:2(4):219-222  

Recent years have seen a significant advancement in liver surgery, particularly due to new technical possibilities. There has been a marked decrease in morbidity following liver resection which is now less than 3 %. Currently, the five-year survival rate of patients after primary liver resection ranges from 25 to 40 % and about 20 % of patients survive for ten years. At present, the preferred treatment of choice is surgical liver resection (by open or laparoscopic approach), however, the introduction of new combined oncological approaches using biological therapy has resulted in a major improvement in long-term outcomes for both primary...

ONCOLOGY TREATMENT OF LIVER TUMORS

Jindřich Fínek

Onkologie. 2008:2(4):223-224  

Hepatocellular carcinoma is the seventh most common malignancy in the world, the causes of mortality among cancer is in third place. Treatment consists of surgical resection or liver transplant. Non-surgical treatment options are limited, a new chance to bring the use of biological medicines.

FOLLOW UP IN PATIENTS WITH DISTANT METASTASES OF COLORECTAL CARCINOMA INTO THE LIVER

Luboš Holubec, Ondřej Topolčan, Jindřich Fínek, Vladislav Třeška, Václav Liška

Onkologie. 2008:2(4):226-228  

The aim of review article is to inform the readers with current problems of follow up of patients with metastases of colorectal carcinoma from a oncologist perspective.

THE POSSIBILITY OF LABORATORY TESTING FOR ONKOLOGICAL PATIENTS

Mirka Nekulová

Onkologie. 2008:2(4):229-232  

The examinations of tumor markers and  the other laboratory parameters in serum, plama or tissue of patients with malignant diagnoses, their validity (sensitivity and specificity), biological half-time,  timing and applications in terms of recommendations of international working groups for tumor markers  are summarized  in the view of clinical oncology. Also individual characteristics for  tumor markers and their accurate  indications are presented  as well as perspective metods for future.

CENTRAL NERVOUS SYSTEM TUMORS IN CHILDREN AND ADOLESCENTS

Markéta Chráčková

Onkologie. 2008:2(4):234-238  

Brain tumors are the most prevalent types of pediatric solid cancer. The prognosis of the patients is still unfavorable. The progress in molecular biology and genetics in the last years designates additional biologic markers and prognostic factors and can facilitate individual treatment. With the collaboration in international expert groups and with using the new treatment modalities and international therapeutical protocols we can increase the chance for survival of patients.

RADIOTHERAPY PROSTATE CANCER

Pavol Dubinský

Onkologie. 2008:2(4):239-245  

Radiotherapy, radical prostatectomy, watchful waiting and hormonal therapy are the basic treatment modalities for prostate cancer. External beam radiotherapy and brachytherapy alone or in combination with other means of treatment represents curative option for non-metastatic disease. Conformal radiotherapy improves toxicity profile by reduction of volumes of irradiated normal tissues. Conformal radio­therapy planning is based on extensive clinical research and is well understood and standardized. There are some unresolved questions and controversies in prostate cancer radiotherapy. The most predominant are as follows: long term treatment outcomes with...

SUBCUTANEOUS ADMINISTRATION OF DRUGS AND FLUIDS IN PALLIATIVE MEDICINE

Ondřej Sláma

Onkologie. 2008:2(4):246-248  

Difficulties in intake of drugs and fluids per os are very often in patients with advanced stages of malignant (however of non-malignant as well) diseases. Possible causes are nausea, vomiting, difficulties in swalloving, confusion and general weakness accompanied by negative attitude to peroral medication. Most of these patients became so candidates for parenteral application of drugs nad liquids.

PSYCHOTHERAPY IN ONCOLOGY

Marie Zemanová

Onkologie. 2008:2(4):249-252  

This article contains a brief outline of the possibility of psychotherapeutic interventions in oncological patients. Psychotherapy is a tool that allows emotional support to patients, helping the patient adapt to the changes that illness brings and supports the integration of changes in family and social system of the patient. Improving communication between patient and physician.

PRIMARY INTRACRANIAL HODGKIN LYMPHOMA IN 12OLD YEAR BOY

Viera Bajčiová

Onkologie. 2008:2(4):253-255  

It is a case study of very rare primary intracranial extracerebral Hodgkins lymphoma in 12 years old boy, based on clinical and radiological picture meningeoma has been supposed. Patient underwent surgery followed with combined oncology treatment – systemic chemotherapy and involved field radiotherapy. The 1st clinical complete remission has been achieved of 4 months duration at the time of presentation.

NODULE GOITRE AS THE FIRST SYMPTOM OF NON-HODGKIN LYMPHOMA/B-CLL: FROM THYROID GLAND DISEASE TO BLOOD DISORDER - CASE REPORT

Peter Kentoš, Katarína Macháleková, Ľubica Váleková, Mikuláš Pura, Peter Szépe, Jana Fedorová, Peter Vaňuga

Onkologie. 2008:2(4):257-259  

Thyroid gland is a rare localization of non-Hodgkin‘s lymphoma (NHL). In extranodal localization, it can be classified as primary extranodal NHL, which has been arised in the tissue, or a secondary extranodal NHL, a metastasis to the tissue. We describe a case of 72-year old female with autoimmune thyroiditis, who underwent thyreoidectomy due to the suspicion of follicular form of papilary thyroid carcinoma. Subsequently, the exact revision of primary histopathological findings was done. This led to the correct diagnosis of thyroid gland infiltration by small lymphocytic lymphoma/B-cell CLL (B-NHL/CLL).

XV. jihočeské onkologické dny

Hana Šiffnerová

Onkologie. 2008:2(4):261-262  

Autodidaktický test č. 4/2008

Onkologie. 2008:2(4):260